---

Luteal Phase Defect (LPD): A necessary tool in assisted reproductive techniques

---

Review Article

Author Details : P R Pant*, Uma Shrivastava, Sabina Simkhada, Swasti Sharma, Chetna Shrestha, Usha Shrestha, Tumla Lacoul

Volume : 8, Issue : 1, Year : 2021

Article Page : 1-9

https://doi.org/10.18231/j.ijogr.2021.001

Suggest article by email

Get Permission

---

Abstract

In Luteal Phase Defect (LPD), endogenous progesterone is insufficient to maintain a functional secretory endometrium and also inhibit embryo growth and implant. In 1960, it was estimated that 20 million pregnancies were exposed to Dydrogesterone in utero. LOTUS I and LOTUS II two major multicenter Phase III studies were conducted on patients who were planning to undergo In Vitro Fertilization (IVF) with or without Intracytoplasmic Sperm Injection (ICSI). The result of both studies shows that Dydrogesterone was non-inferior to micronized vaginal progesterone, which was the presence of fetal heartbeats at 12 weeks
of gestation. Progesterone which can be administered either by oral preparation, vaginal administration along with optimal use of  estrogen and Gonadotropin-Releasing Hormon (GnRH) agonist drugs is used in the treatment of LPD. Studies have suggested the use of Dydrogesterone in fresh IVF cycles and Luteal Phase Support (LPS) is continued till 10–12 weeks. However, it may be stopped at the time of β-hCG becoming positive or visualization of a fetal heartbeat.

Keywords: LPD, LOTUS, Progesterone, GnRH, ART, FET, Dydrogesterone.

How to cite : Pant P R , Shrivastava U , Simkhada S , Sharma S , Shrestha C , Shrestha U , Lacoul T , Luteal Phase Defect (LPD): A necessary tool in assisted reproductive techniques. Indian J Obstet Gynecol Res 2021;8(1):1-9

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.